Dr. Navratil is the SVP of R&D at HTG Molecular Diagnostics, responsible for the oversight and execution of the company’s research and development plans, as well HTG’s commercial laboratory operations. Prior to joining HTG, Dr. Navratil served in a variety of product development leadership roles, most recently with Beckman Coulter Diagnostics and Danaher, where he led the development of in vitro diagnostic tests for a variety of disease states. Dr. Navratil earned his MS. degree in Biochemistry and Biotechnology, and PhD. in Biotechnology from the Slovak University of Technology, and completed his postdoctoral training at the Linkoping University in Sweden and at the University of Minnesota. Dr. Navratil is a member of the editorial board of Biotechnology Letters.